Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:36 pm Purchase | 2021-12-31 | 13G | Sage Therapeutics, Inc. SAGE | BB Biotech AG | 3,170,104 5.400% | 210,000 (+7.09%) | Filing History |
| 2022-02-11 4:34 pm Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BB Biotech AG | 0 0.000% | -2,680,283 (Position Closed) | Filing History |
| 2022-01-18 09:29 am Purchase | 2022-01-06 | 13D | Radius Recycling, Inc. RDUS | BB Biotech AG | 8,255,714 17.400% | 800,000 (+10.73%) | Filing History |
| 2021-09-15 6:23 pm Purchase | 2021-09-10 | 13G | Mersana Therapeutics, Inc. MRSN | BB Biotech AG | 4,135,000 5.800% | 4,135,000 (New Position) | Filing History |
| 2021-08-17 1:57 pm Purchase | 2021-08-16 | 13G | ESSA Pharma Inc. EPIX | BB Biotech AG | 4,765,814 10.800% | 2,780,000 (+139.99%) | Filing History |
| 2021-08-11 5:04 pm Purchase | 2021-08-04 | 13G | Sage Therapeutics, Inc. SAGE | BB Biotech AG | 2,960,104 5.000% | 2,960,104 (New Position) | Filing History |
| 2021-06-11 5:25 pm Purchase | 2021-06-09 | 13G | MacroGenics, Inc. MGNX | BB Biotech AG | 6,025,564 10.000% | 1,210,000 (+25.13%) | Filing History |
| 2021-05-28 5:00 pm Purchase | 2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,477,964 15.900% | 530,000 (+13.42%) | Filing History |
| 2021-05-27 4:33 pm Purchase | 2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 4,477,964 15.900% | 1,085,000 (+31.98%) | Filing History |
| 2021-05-05 5:20 pm Purchase | 2021-04-29 | 13G | ESSA Pharma Inc. EPIX | BB Biotech AG | 1,985,814 5.100% | 1,985,814 (New Position) | Filing History |
| 2021-04-26 1:11 pm Purchase | 2021-04-07 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 636,175 17.000% | 210,819 (+49.56%) | Filing History |
| 2021-02-12 5:18 pm Purchase | 2020-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | BB Biotech AG | 3,538,419 4.400% | 80,000 (+2.31%) | Filing History |
| 2021-02-12 5:07 pm Purchase | 2020-12-31 | 13G | Molecular Templates, Inc. MTEM | BB Biotech AG | 425,355 12.800% | 76,689 (+21.99%) | Filing History |
| 2021-02-12 5:01 pm Sale | 2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | BB Biotech AG | 3,970,000 2.900% | -3,993,056 (-50.14%) | Filing History |
| 2021-02-12 4:58 pm Purchase | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | BB Biotech AG | 3,947,964 14.200% | 220,000 (+5.90%) | Filing History |
| 2021-02-12 4:54 pm Sale | 2020-12-31 | 13G | Scholar Rock Holding Corporation SRRK | BB Biotech AG | 2,255,651 6.700% | -378,815 (-14.38%) | Filing History |
| 2021-02-12 4:52 pm Purchase | 2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB Biotech AG | 453,315 9.800% | 298,248 (+192.33%) | Filing History |
| 2021-02-12 4:51 pm Unchanged | 2020-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | BB Biotech AG | 2,680,283 7.200% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:48 pm Purchase | 2020-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB Biotech AG | 2,602,858 5.300% | 200,000 (+8.32%) | Filing History |
| 2021-02-12 4:45 pm Sale | 2020-12-31 | 13G | Myovant Sciences Ltd. MYOV | BB Biotech AG | 4,757,039 5.300% | -58,070 (-1.21%) | Filing History |